Artykuły udostępnione publicznie: - ARSIME DEMJAHAWięcej informacji
Niedostępne w żadnym miejscu: 2
Persistent negative symptoms in recent-onset psychosis: relationship to treatment response and psychosocial functioning
P Bucci, A Mucci, IW van Rossum, C Aiello, C Arango, L Baandrup, ...
European Neuropsychopharmacology 34, 76-86, 2020
Upoważnienia: UK Medical Research Council, Government of Spain
PSYCHOPATHOLOGICAL DIMENSIONS IN THE FIRST ONSET PSYCHOSIS STUDY: ASSOCIATIONS WITH CLINICAL, NEUROBIOLOGICAL AND SOCIODEMOGRAPHIC VARIABLES
A Demjaha, K Morgan, C Morgan, S Landau, K Dean, A Reichenberg, ...
Schizophrenia Research 102 (1-3), 224-225, 2008
Upoważnienia: US National Institutes of Health
Dostępne w jakimś miejscu: 34
Antipsychotic treatment resistance in schizophrenia associated with elevated glutamate levels but normal dopamine function
A Demjaha, A Egerton, RM Murray, S Kapur, OD Howes, JM Stone, ...
Biological psychiatry 75 (5), e11-e13, 2014
Upoważnienia: UK Medical Research Council
Two distinct patterns of treatment resistance: clinical predictors of treatment resistance in first-episode schizophrenia spectrum psychoses
J Lally, O Ajnakina, M Di Forti, A Trotta, A Demjaha, A Kolliakou, ...
Psychological medicine 46 (15), 3231-3240, 2016
Upoważnienia: UK Medical Research Council, National Institute for Health Research, UK
Antipsychotic treatment resistance in first-episode psychosis: prevalence, subtypes and predictors
A Demjaha, JM Lappin, D Stahl, MX Patel, JH MacCabe, OD Howes, ...
Psychological medicine 47 (11), 1981-1989, 2017
Upoważnienia: UK Medical Research Council, National Institute for Health Research, UK
Dopaminergic Function in the Psychosis Spectrum: An [18F]-DOPA Imaging Study in Healthy Individuals With Auditory Hallucinations
OD Howes, P Shotbolt, M Bloomfield, K Daalman, A Demjaha, ...
Schizophrenia bulletin 39 (4), 807-814, 2013
Upoważnienia: UK Medical Research Council
Association of age, antipsychotic medication, and symptom severity in schizophrenia with proton magnetic resonance spectroscopy brain glutamate level: a mega-analysis of …
K Merritt, PK McGuire, A Egerton, A Aleman, W Block, OJN Bloemen, ...
JAMA psychiatry 78 (6), 667-681, 2021
Upoważnienia: US National Institutes of Health, Canadian Institutes of Health Research …
Association between symptom dimensions and categorical diagnoses of psychosis: a cross-sectional and longitudinal investigation
M Russo, SZ Levine, A Demjaha, M Di Forti, S Bonaccorso, P Fearon, ...
Schizophrenia bulletin 40 (1), 111-119, 2014
Upoważnienia: UK Medical Research Council
Interaction testing and polygenic risk scoring to estimate the association of common genetic variants with treatment resistance in schizophrenia
AF Pardiñas, SE Smart, IR Willcocks, PA Holmans, CA Dennison, ...
JAMA psychiatry 79 (3), 260-269, 2022
Upoważnienia: Swiss National Science Foundation, US National Institutes of Health …
Natural Language Processing markers in first episode psychosis and people at clinical high-risk
SE Morgan, K Diederen, PE Vértes, SHY Ip, B Wang, B Thompson, ...
Translational psychiatry 11 (1), 630, 2021
Upoważnienia: UK Engineering and Physical Sciences Research Council, UK Medical Research …
Dopamine function in cigarette smokers: an [18F]-DOPA PET study
MAP Bloomfield, F Pepper, A Egerton, A Demjaha, G Tomasi, ...
Neuropsychopharmacology 39 (10), 2397-2404, 2014
Upoważnienia: UK Medical Research Council, National Institute for Health Research, UK
A potential biomarker for treatment stratification in psychosis: evaluation of an [18F] FDOPA PET imaging approach
M Veronese, B Santangelo, S Jauhar, E D’Ambrosio, A Demjaha, ...
Neuropsychopharmacology 46 (6), 1122-1132, 2021
Upoważnienia: UK Medical Research Council, National Institute for Health Research, UK …
Lower speech connectedness linked to incidence of psychosis in people at clinical high risk
TJ Spencer, B Thompson, D Oliver, K Diederen, A Demjaha, S Weinstein, ...
Schizophrenia research 228, 493-501, 2021
Upoważnienia: UK Medical Research Council, National Institute for Health Research, UK
Biological and psychosocial risk factors for psychotic major depression
M Heslin, R Desai, JM Lappin, K Donoghue, B Lomas, U Reininghaus, ...
Social psychiatry and psychiatric epidemiology 51, 233-245, 2016
Upoważnienia: UK Medical Research Council, National Institute for Health Research, UK
Variability and magnitude of brain glutamate levels in schizophrenia: a meta and mega-analysis
K Merritt, RA McCutcheon, A Aleman, S Ashley, K Beck, W Block, ...
Molecular psychiatry 28 (5), 2039-2048, 2023
Upoważnienia: US National Institutes of Health, Canadian Institutes of Health Research, UK …
The effect of the environment on symptom dimensions in the first episode of psychosis: a multilevel study
FJ Oher, A Demjaha, D Jackson, C Morgan, P Dazzan, K Morgan, ...
Psychological Medicine 44 (11), 2419-2430, 2014
Upoważnienia: UK Medical Research Council, National Institute for Health Research, UK …
Outcomes following first-episode psychosis–Why we should intervene early in all ages, not only in youth
JM Lappin, M Heslin, PB Jones, GA Doody, UA Reininghaus, A Demjaha, ...
Australian & New Zealand Journal of Psychiatry 50 (11), 1055-1063, 2016
Upoważnienia: UK Medical Research Council, National Institute for Health Research, UK
Neuropsychological function at first episode in treatment-resistant psychosis: findings from the ÆSOP-10 study
E Kravariti, A Demjaha, J Zanelli, F Ibrahim, C Wise, JH MacCabe, ...
Psychological medicine 49 (12), 2100-2110, 2019
Upoważnienia: UK Medical Research Council, National Institute for Health Research, UK …
Gender differences in neuropsychological performance across psychotic disorders–a multi-centre population based case-control study
J Zanelli, K Morgan, P Dazzan, C Morgan, M Russo, I Pilecka, P Fearon, ...
PloS one 8 (10), e77318, 2013
Upoważnienia: UK Medical Research Council
Self esteem and self agency in first episode psychosis: Ethnic variation and relationship with clinical presentation
S Ciufolini, C Morgan, K Morgan, P Fearon, J Boydell, G Hutchinson, ...
Psychiatry Research 227 (2-3), 213-218, 2015
Upoważnienia: National Institute for Health Research, UK
Informacje na temat publikacji i finansowania automatycznie określa program komputerowy